Viewing StudyNCT00211068



Ignite Creation Date: 2024-05-05 @ 12:01 PM
Last Modification Date: 2024-10-26 @ 9:18 AM
Study NCT ID: NCT00211068
Status: COMPLETED
Last Update Posted: 2013-04-30
First Post: 2005-09-13

Brief Title: A Study of Risk Factors for Anti-erythropoietin Antibody Positive Pure Red Cell Aplasia Among Patients With Chronic Kidney Disease Receiving Epoetin Alfa
Sponsor: Johnson Johnson Pharmaceutical Research Development LLC
Organization: Johnson Johnson Pharmaceutical Research Development LLC

Conditions & Keywords Data

Conditions:
Name
Pure Red-cell Aplasia
Keywords:
Name View
Anemia View
Pure red-cell aplasia View
Chronic kidney failure View
Epoetin alfa Eprex View
Erythropoietin View
Kidney disease View